JPWO2021112220A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021112220A5
JPWO2021112220A5 JP2021562745A JP2021562745A JPWO2021112220A5 JP WO2021112220 A5 JPWO2021112220 A5 JP WO2021112220A5 JP 2021562745 A JP2021562745 A JP 2021562745A JP 2021562745 A JP2021562745 A JP 2021562745A JP WO2021112220 A5 JPWO2021112220 A5 JP WO2021112220A5
Authority
JP
Japan
Prior art keywords
adrenomedullin
peptide
group
agent according
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562745A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021112220A1 (https=
JP7498882B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/045235 external-priority patent/WO2021112220A1/ja
Publication of JPWO2021112220A1 publication Critical patent/JPWO2021112220A1/ja
Publication of JPWO2021112220A5 publication Critical patent/JPWO2021112220A5/ja
Application granted granted Critical
Publication of JP7498882B2 publication Critical patent/JP7498882B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562745A 2019-12-05 2020-12-04 異常タンパク質蓄積性神経変性疾患の治療剤 Active JP7498882B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019220695 2019-12-05
JP2019220695 2019-12-05
PCT/JP2020/045235 WO2021112220A1 (ja) 2019-12-05 2020-12-04 異常タンパク質蓄積性神経変性疾患の治療剤

Publications (3)

Publication Number Publication Date
JPWO2021112220A1 JPWO2021112220A1 (https=) 2021-06-10
JPWO2021112220A5 true JPWO2021112220A5 (https=) 2022-07-29
JP7498882B2 JP7498882B2 (ja) 2024-06-13

Family

ID=76221768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562745A Active JP7498882B2 (ja) 2019-12-05 2020-12-04 異常タンパク質蓄積性神経変性疾患の治療剤

Country Status (2)

Country Link
JP (1) JP7498882B2 (https=)
WO (1) WO2021112220A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2182978A4 (en) * 2007-07-20 2012-03-21 Sanomune Inc TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN
JOP20190001B1 (ar) 2011-11-03 2022-03-15 Bayer Pharma AG عقار أولي معتمد على جليكول عديد إثيلين من أدرينومدالين واستخدامه
CN106164088B (zh) * 2014-03-20 2021-11-23 国立大学法人宫崎大学 长效肾上腺髓质素衍生物
NZ740534A (en) * 2015-09-18 2019-07-26 Univ Miyazaki Long-acting adrenomedullin derivative

Similar Documents

Publication Publication Date Title
FI72732B (fi) Foerfarande foer framstaellning av nya, i 8-staellning aminosyraestergrupp innehaollande, angiotensin-ii-antagoniserande oktapeptidestrar.
CN110229216B (zh) 具有改善的药代动力学性质的坎普他汀类肽
AU2012326026B2 (en) Peptidomimetic macrocyles
JP2022514255A5 (https=)
BR112014015156A2 (pt) análogos de insulina à base de ctp, seus métodos de produção e uso no tratamento de hiperglicemia, bem como sequência de ácido nucleico e célula hospedeira
JP2020502051A5 (https=)
WO2004020462A1 (ja) Ｃｘｃｒ４拮抗薬およびその用途
JP2011518179A5 (https=)
US20170037105A1 (en) Peptidomimetic macrocycles
CN105683156A (zh) 含有肽修饰剂的氨基二酸
JP2009532384A5 (https=)
BG107020A (bg) Кахалалидни съединения
CN101268099A (zh) 用于治疗性干预的y4选择性受体激动剂
AU2024240921A1 (en) Incretin analog and use thereof
JPH06506699A (ja) 抗血栓性ペプチドおよび偽ペプチド
CN103501801A (zh) 甲状旁腺激素类似物、其组合物和用途
CN101379076A (zh) 新化合物
JPWO2021112220A5 (https=)
JP2019038772A5 (https=)
CN104334574B (zh) 附加唾液酸化糖链的多肽
EP2848629B1 (en) Synthetic peptides wtih a non-narcotic type of analgesic effect
AU684511B2 (en) Oligopeptides derived from C-reactive protein fragments
JPH0770178A (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
RU2760133C1 (ru) Амиды гептапептида для лечения HMGB1-зависимых заболеваний
JP2025525217A (ja) グルカゴン様ペプチド－１受容体アンタゴニスト